Companies: 10,795·Total market cap: $144.5T
NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc.

NRXPNASDAQHealthcare● Active
$4.33
+$0.19(+4.59%)
Market Cap$74847142
P/E Ratio—
52W High$5.055
52W Low$1.62
ForecastMarket CapPE Ratio

NRx Pharmaceuticals, Inc.（NRXP）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

nrxp · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

SellBuy

Buy

5 位分析师

共识

评级分布

Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
合计: 5 · 买入占比: 100.0%

12 个月目标价

High

$2.00

Consensus

$2.00

-53.8% upside

Low

$2.00

Median: $2 · Last Close: $4.33

NRx Pharmaceuticals, Inc.（NRXP）的分析师共识为 Buy，基于过去 3 个月内 5 位华尔街分析师的评级。NRXP 的 12 个月平均目标价为 $2.00，相对当前价 $4.33 代表 -53.8% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

Bull

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$4.55↑ 5.00%

1-day model range: $4.48–$4.61. Peak: $4.61 (+5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$3-31.8%
2028$2-42.6%
2029$2-47.1%
2030$2-49.2%
2031—-50.3%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

93%0%7%
13Buy
0Neutral
1Sell
RSI (14)72.0Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · NRXP · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$4.24BUY
MA 10$4.33BUY
MA 20$3.69BUY
MA 50$3.06BUY
MA 100$2.51BUY
MA 200$2.60BUY
Current $NRXP · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.23BUY
EMA 10$4.12BUY
EMA 20$3.82BUY
EMA 50$3.24BUY
EMA 100$2.86BUY
EMA 200$2.68BUY
Current $NRXP · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
D. Boral Capital2026-05-05
Maintains
Buy→Buy
Ascendiant Capital2026-04-27
Maintains
Buy→Buy
HC Wainwright & Co.2026-04-27
Maintains
Buy→Buy
D. Boral Capital2026-04-23
Maintains
Buy→Buy
D. Boral Capital2026-04-20
Maintains
Buy→Buy
BTIG2026-03-24
Maintains
Buy→Buy
D. Boral Capital2026-03-24
Maintains
Buy→Buy
D. Boral Capital2026-03-17
Maintains
Buy→Buy
D. Boral Capital2026-03-16
Maintains
Buy→Buy
D. Boral Capital2026-03-09
Maintains
Buy→Buy

Wall Street analysts have recently issued updated ratings on NRx Pharmaceuticals, Inc. (NRXP) stock. Of the recent 60 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover NRXP.

分析师推荐趋势

Buy ratings4 → 1↓ 3
Hold ratings0 → 0
Sell ratings0 → 0

NRXP analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$21M

↓ 95.9% YoY

Revenue Next Year

$204M

↑ 886.7% YoY

EPS This Year

$-0.17

EPS Next Year

$0.23

↓ 239.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NRXP EPS of $-0.17 for the current fiscal year, based on estimates from 2 analysts. The NRXP revenue forecast is $21M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

NRXP 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NRXP 的共识目标价为 $2.00（-53.8% 上行空间），分析师共识为 Buy。

NRXP 的短期预测（明日）为 $4.55（+5.00%）。 NRXP 对 2027 年的股价预测均值为 $3。 NRXP 对 2030 年的预测区间为 $2–$3。

NRx Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 NRXP。NRXP 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

NRXP 预测 · 8 个问题

根据 5 位华尔街分析师，NRXP 的 12 个月平均目标价为 $2.00，最高 $2.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $4.33，隐含约 -53.8% 的上行空间。

NRXP 目标价NRXP 分析师目标价NRXP 12个月目标价目标价 NRXP

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.